Estimation of Renal Cell Carcinoma Treatment Effects From Disease Progression Modeling

E-ISSN： 1532-6535|93|4|345-351

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.93, Iss.4, 2013-04, pp. : 345-351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Operative Therapy in Disease Progression and Local Recurrence of Renal Cell Carcinoma

Urologia Internationalis, Vol. 63, Iss. 1, 1999-12 ,pp. : 10-15

Karger

Access to resources Recommend Favorite

Sunitinib Treatment for Patients with Advanced Clear-Cell Renal-Cell Carcinoma after Progression on Sorafenib

Oncology, Vol. 76, Iss. 5, 2009-03 ,pp. : 350-354

Karger

Access to resources Recommend Favorite

Partial nephrectomy for the treatment of renal cell carcinoma (RCC) and the risk of end‐stage renal disease (ESRD)

BJU INTERNATIONAL, Vol. 115, Iss. 6, 2015-06 ,pp. : 897-906

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase 2, single‐arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1647-1655

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of a New Isolated Metastasis during Sunitinib Treatment in Renal Cell Carcinoma Patients: A Lesson from Two Cases

Urologia Internationalis, Vol. 86, Iss. 2, 2010-12 ,pp. : 245-248

Karger

Access to resources Recommend Favorite